Expanding evidence leads to new pharmacogenomics payer coverage.
作者信息
Empey Philip E, Pratt Victoria M, Hoffman James M, Caudle Kelly E, Klein Teri E
机构信息
Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
出版信息
Genet Med. 2021 May;23(5):830-832. doi: 10.1038/s41436-021-01117-w. Epub 2021 Feb 24.
Abstract
摘要
相似文献
1
Expanding evidence leads to new pharmacogenomics payer coverage.
Genet Med. 2021 May;23(5):830-832. doi: 10.1038/s41436-021-01117-w. Epub 2021 Feb 24.
2
Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice.
Pharmacogenomics. 2010 May;11(5):657-60. doi: 10.2217/pgs.10.46.
3
Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
Am J Health Syst Pharm. 2000 May 1;57(9):887-98; quiz 899-901. doi: 10.1093/ajhp/57.9.887.
4
Pharmacogenomics guidelines: Current status and future development.
Clin Exp Pharmacol Physiol. 2019 Aug;46(8):689-693. doi: 10.1111/1440-1681.13097. Epub 2019 May 16.
5
Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications.
J Mol Med (Berl). 2003 Mar;81(3):135-40. doi: 10.1007/s00109-002-0415-6.
6
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
Clin Genet. 1999 Oct;56(4):247-58. doi: 10.1034/j.1399-0004.1999.560401.x.
7
Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Drug Metab Pers Ther. 2016 Mar;31(1):25-34. doi: 10.1515/dmpt-2015-0042.
8
Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Biotechniques. 2005 Oct;39(10 Suppl):S565-8. doi: 10.2144/000112043.
9
Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Biotechniques. 2005 Oct;39(4):565-8.
10
The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil.
Pharmacology. 2000 Sep;61(3):199-203. doi: 10.1159/000028401.
引用本文的文献
1
Analyzing pharmacogenetics cost effectiveness and savings across common health conditions in the United States.
Pharmacogenomics J. 2025 Jul 8;25(4):18. doi: 10.1038/s41397-025-00376-z.
2
Evaluation of pharmacogenomic testing to identify cytochrome P450 and SLCO1B1 enzymes and adverse drug events: A non-experimental observational research.
Medicine (Baltimore). 2025 Apr 4;104(14):e42031. doi: 10.1097/MD.0000000000042031.
3
A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence-Based Pharmacogenomic Information.
Clin Pharmacol Ther. 2025 Jun;117(6):1793-1802. doi: 10.1002/cpt.3617. Epub 2025 Mar 3.
4
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice.
Clin Pharmacol Ther. 2025 May;117(5):1194-1208. doi: 10.1002/cpt.3567. Epub 2025 Jan 31.
5
Pharmacogenetics: Opportunities for the Research Program and Other Large Data Sets to Advance the Field.
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):111-130. doi: 10.1146/annurev-pharmtox-061724-080718.
6
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned.
Clin Pharmacol Ther. 2024 Oct;116(4):914-931. doi: 10.1002/cpt.3402. Epub 2024 Aug 21.
7
Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US.
Support Care Cancer. 2024 Jul 9;32(8):497. doi: 10.1007/s00520-024-08674-1.
8
Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association.
Circulation. 2024 Aug 6;150(6):e129-e150. doi: 10.1161/CIR.0000000000001257. Epub 2024 Jun 20.
9
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic.
PCN Rep. 2022 Jun 22;1(2):e26. doi: 10.1002/pcn5.26. eCollection 2022 Jun.
10
The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review.
Psychol Med. 2023 Dec;53(16):7983-7993. doi: 10.1017/S0033291723002817. Epub 2023 Sep 29.
本文引用的文献
1
Delivering on the value proposition of precision medicine: the view from healthcare payers.
Am J Manag Care. 2018 Apr;24(4):177-179.
2
Documenting Pharmacogenomic Testing with CPT Codes.
J AHIMA. 2016 Jan;87(1):56-9.
Zotero 插件